Dyazide and Cefdinir drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dyazide (hydrochlorothiazide; triamterene) and Cefdinir (cefdinir). Common drug interactions include pain among females and abdominal discomfort among males.

The phase IV clinical study analyzes what interactions people have when they take Dyazide and Cefdinir. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Dyazide?

Dyazide has active ingredients of hydrochlorothiazide; triamterene. It is often used in high blood pressure. eHealthMe is studying from 11,506 Dyazide users. Check the latest studies of Dyazide.

What is Cefdinir?

Cefdinir has active ingredients of cefdinir. It is often used in sinusitis. eHealthMe is studying from 9,210 Cefdinir users. Check the latest studies of Cefdinir.

On Jul, 23, 2026

14 people who take Dyazide and Cefdinir together, and have interactions are studied.

What are the common drug interactions of Dyazide and Cefdinir, by gender? *:

female:

Pain
Chronic kidney disease
Injection site pruritus (severe itching at injection site)
Renal failure (kidney dysfunction)
Weight increased
Allergic sinusitis
Febrile neutropenia (fever with reduced white blood cells)
Nasopharyngitis (inflammation of the nasopharynx)
Seasonal allergy (allergic condition due to certain season)
Ankle fracture

male:

Abdominal discomfort
Affective disorder (mental disorder)
Somnolence (a state of near-sleep, a strong desire for sleep)
Therapeutic response unexpected
Vomiting
Weight decreased
Blood testosterone decreased
Decreased appetite
Dehydration (dryness resulting from the removal of water)
Fatigue (feeling of tiredness)

What are the common drug interactions of Dyazide and Cefdinir, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Chronic kidney disease
Renal failure (kidney dysfunction)
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)

50-59:

Chronic kidney disease
Renal failure (kidney dysfunction)
Drug hypersensitivity
Nephrogenic anaemia (anaemia due to kidney disease)

60+:

Febrile neutropenia (fever with reduced white blood cells)
Ankle fracture
Eyelid irritation
Fall
Flank pain (a distressing sensation experienced around the lower back and the upper abdomen)
Infusion site erythema (reddening of the skin at infusion site)
Infusion site extravasation (flow of (blood or lymph) from infusion site)
Infusion site pain
Infusion site pruritus (severe itching at infusion site)
Infusion site reaction

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 35.71%
Immunodeficiency Common Variable: 5 people, 35.71%
Pain: 4 people, 28.57%
Nausea (feeling of having an urge to vomit): 3 people, 21.43%
Type 2 Diabetes: 2 people, 14.29%
Anaemia (lack of blood): 2 people, 14.29%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 14.29%
Blood Creatinine Increased: 2 people, 14.29%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 14.29%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Dyazide and Cefdinir?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously